BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 17343330)

  • 1. 5-fluorouracil cardiotoxicity is a rare, dose and schedule-dependent adverse event: a prospective study.
    Tsavaris N; Kosmas C; Vadiaka M; Skopelitis E; Kopteridis P; Pamouki S; Efremidis M; Kasparian H; Moisakis I; Sakelariou D; Koufos C
    J BUON; 2005; 10(2):205-11. PubMed ID: 17343330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiotoxicity of fluoropyrimidines in different schedules of administration: a prospective study.
    Kosmas C; Kallistratos MS; Kopterides P; Syrios J; Skopelitis H; Mylonakis N; Karabelis A; Tsavaris N
    J Cancer Res Clin Oncol; 2008 Jan; 134(1):75-82. PubMed ID: 17636329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiotoxicity following different doses and schedules of 5-fluorouracil administration for malignancy -- a survey of 427 patients.
    Tsavaris N; Kosmas C; Vadiaka M; Efremidis M; Zinelis A; Beldecos D; Sakelariou D; Koufos C; Stamatelos G
    Med Sci Monit; 2002 Jun; 8(6):PI51-7. PubMed ID: 12070449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cardiotoxicity of continuous intravenous infusion of 5-fluorouracil: clinical study, prevention and physiopathology. Apropos of 13 cases].
    de Forni M; Bugat R; Sorbette F; Delay M; Bachaud JM; Chevreau C
    Bull Cancer; 1990; 77(5):429-38. PubMed ID: 2205312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiotoxicity of 5-fluorouracil in 1350 patients with no prior history of heart disease.
    Tsibiribi P; Descotes J; Lombard-Bohas C; Barel C; Bui-Xuan B; Belkhiria M; Tabib A; Timour Q
    Bull Cancer; 2006 Mar; 93(3):E27-30. PubMed ID: 16567310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiotoxicity of high-dose continuous infusion fluorouracil: a prospective clinical study.
    de Forni M; Malet-Martino MC; Jaillais P; Shubinski RE; Bachaud JM; Lemaire L; Canal P; Chevreau C; Carrié D; Soulié P
    J Clin Oncol; 1992 Nov; 10(11):1795-801. PubMed ID: 1403060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cardiotoxicity of 5-fluorouracil. Personal cases and review of the literature].
    Segalini G; Labianca R; Beretta GD; Borsotti E; Calasso F; Carini L; De Ceglia S; Rocca A
    G Ital Cardiol; 1987 Sep; 17(9):781-5. PubMed ID: 3319758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomised trial comparing three different schedules of infusional 5FU and raltitrexed alone as first-line therapy in metastatic colorectal cancer. Final results of the Fédération Francophone de Cancérologie Digestive (FFCD) 9601 trial.
    Ducreux M; Bouche O; Pignon JP; Mousseau M; Raoul JL; Cassan P; Leduc B; Berger C; Dunant A; Fournet J; Bedenne L;
    Oncology; 2006; 70(3):222-30. PubMed ID: 16816536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of refractory metastatic breast cancer with 5-fluorouracil and levofolinic acid as 48 hours continuous venous infusion.
    Gebbia V; Mauceri G; Testa A; Tirrito M; Varvara F; Cucchiara A; Borsellino N; Girlando A; Ferrara M; Caruso F
    Anticancer Res; 1999; 19(3B):2289-92. PubMed ID: 10472346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Chronotherapy with high dose carboplatin, 5-fluorouracil and leucovorin in advanced colorectal carcinoma].
    Popov I; Jelić S; Radosavljević D; Nikolić-Tomasević A
    Srp Arh Celok Lek; 1998; 126(9-10):355-61. PubMed ID: 9863407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thymidylate synthase protein expression in advanced colon cancer: correlation with the site of metastasis and the clinical response to leucovorin-modulated bolus 5-fluorouracil.
    Cascinu S; Aschele C; Barni S; Debernardis D; Baldo C; Tunesi G; Catalano V; Staccioli MP; Brenna A; Muretto P; Catalano G
    Clin Cancer Res; 1999 Aug; 5(8):1996-9. PubMed ID: 10473077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiotoxicity of de Gramont's regimen: incidence, clinical characteristics and long-term follow-up.
    Meydan N; Kundak I; Yavuzsen T; Oztop I; Barutca S; Yilmaz U; Alakavuklar MN
    Jpn J Clin Oncol; 2005 May; 35(5):265-70. PubMed ID: 15855175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevation of thymidylate synthase following 5-fluorouracil treatment is prevented by the addition of leucovorin in murine colon tumors.
    Van der Wilt CL; Pinedo HM; Smid K; Peters GJ
    Cancer Res; 1992 Sep; 52(18):4922-8. PubMed ID: 1516048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of high-dose leucovorin and 5-fluorouracil chemotherapy regimen on P wave duration and dispersion.
    Ceyhan C; Meydan N; Barutca S; Tekten T; Onbasili AO; Ozturk B; Unal S; Bayrak I
    J Clin Pharm Ther; 2004 Jun; 29(3):267-71. PubMed ID: 15153089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolonged 5-fluorouracil infusion in patients with metastatic colon cancer pretreated with bolus schedule of the same agent.
    Tralongo P; Di Mari A; Scibilia G; Bosco V; Giudice A; Respini D; Failla G
    Anticancer Res; 1995; 15(2):635-8. PubMed ID: 7539242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toxicity during l-LV/5FU adjuvant chemotherapy as a modified RPMI regimen for patients with colorectal cancer.
    Hotta T; Takifuji K; Arii K; Yokoyama S; Matsuda K; Higashiguchi T; Tominaga T; Oku Y; Yamaue H
    Oncol Rep; 2005 Aug; 14(2):433-9. PubMed ID: 16012727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase III study comparing a semimonthly with a monthly regimen of fluorouracil and leucovorin as adjuvant treatment for stage II and III colon cancer patients: final results of GERCOR C96.1.
    André T; Quinaux E; Louvet C; Colin P; Gamelin E; Bouche O; Achille E; Piedbois P; Tubiana-Mathieu N; Boutan-Laroze A; Flesch M; Lledo G; Raoul Y; Debrix I; Buyse M; de Gramont A
    J Clin Oncol; 2007 Aug; 25(24):3732-8. PubMed ID: 17704423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo potentiation of 5-fluorouracil by leucovorin in murine colon carcinoma.
    Nadal JC; Van Groeningen CJ; Pinedo HM; Peters GJ
    Biomed Pharmacother; 1988; 42(6):387-93. PubMed ID: 3064823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum cardiac troponin I levels and ECG/Echo monitoring in breast cancer patients undergoing high-dose (7 g/m(2)) cyclophosphamide.
    Morandi P; Ruffini PA; Benvenuto GM; La Vecchia L; Mezzena G; Raimondi R
    Bone Marrow Transplant; 2001 Aug; 28(3):277-82. PubMed ID: 11535996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cardiotoxicity of 5-fluorouracil].
    Pan L; Yang X; Song H
    Zhonghua Fu Chan Ke Za Zhi; 1996 Feb; 31(2):86-9. PubMed ID: 8758800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.